AngioDynamics (ANGO) news
Recent news
Angiodynamics, Inc.: H.C. Wainwright cuts target price to $18 from $19
AInvest Wire · 2d agoAngiodynamics, Inc.: For FY2027 tariff impact expected broadly similar to FY2026, excluding tariff refunds
Angiodynamics, Inc. has indicated that the impact of tariffs for fiscal year 2027 is expected to be broadly similar to that of fiscal year 2026, excluding any tariff refunds that may be received. This projection suggests a continuation of the company’s current cost structure related to…
AInvest Wire · 7d agoAngiodynamics 1Q net sales $80.9M, +6.9% y/y
AInvest Wire · 7d agoAngo still sees FY adj loss/shr 24C to 29C, est. loss/shr 27C
AngioDynamics, Inc. (ANGO) continues to project an adjusted loss per share in the range of 24 cents to 29 cents for the fiscal year, with current estimates pointing to a loss of 27 cents per share. This outlook reflects ongoing challenges within the medical device sector, including competitive…
AInvest Wire · 7d agoAngiodynamics Q1 sales USD 80.9 million vs. IBES estimate USD 80.5 million
AInvest Wire · 7d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.